Kui Liu
Shenzhen HighTide Biopharmaceutical Ltd.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kui Liu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 02:57 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT06415773 · Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With MetforminShenzhen HighTide Biopharmaceutical Ltd. · completed · T2DM (Type 2 Diabetes Mellitus) · study director
- Ph2NCT06411275 · A Phase 2 Study of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Diet and ExerciseShenzhen HighTide Biopharmaceutical Ltd. · completed · Type 2 Diabetes Mellitus · study director
- Ph3NCT06353347 · Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With MetforminShenzhen HighTide Biopharmaceutical Ltd. · completed · Type 2 Diabetes Mellitus · study director
- Ph3NCT06350890 · Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 DiabetesShenzhen HighTide Biopharmaceutical Ltd. · completed · T2DM (Type 2 Diabetes Mellitus) · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 02:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 02:57 UTC. The ranking covers the 200 most relevant of 727 PubMed records, and a shared surname and initials can bring in a namesake. All 727 on PubMed
- Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.N Engl J Med · 20081,523 citationsRCR 33.5
- Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.N Engl J Med · 2019660 citationsRCR 33.2
- Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.N Engl J Med · 2020582 citationsRCR 36.0
- 465 citationsRCR 19.0
- Rosuvastatin for sepsis-associated acute respiratory distress syndrome.N Engl J Med · 2014460 citationsRCR 14.5
- 326 citationsRCR 43.2
- Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant.Neurology · 2012248 citationsRCR 9.5
- 247 citationsRCR 8.6
- Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials.Biol Psychiatry · 2016228 citationsRCR 10.8
- Intraoperative high dose fentanyl induces postoperative fentanyl tolerance.Can J Anaesth · 1999220 citationsRCR 7.8